Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Accumulated Depreciation & Amortization (2017 - 2020)

Historic Accumulated Depreciation & Amortization for Cogent Biosciences (COGT) over the last 4 years, with Q4 2020 value amounting to $412000.0.

  • Cogent Biosciences' Accumulated Depreciation & Amortization fell 9110.34% to $412000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $412000.0, marking a year-over-year decrease of 9110.34%. This contributed to the annual value of $412000.0 for FY2020, which is 9110.34% down from last year.
  • Per Cogent Biosciences' latest filing, its Accumulated Depreciation & Amortization stood at $412000.0 for Q4 2020, which was down 9110.34% from $4.6 million recorded in Q4 2019.
  • Cogent Biosciences' Accumulated Depreciation & Amortization's 5-year high stood at $4.6 million during Q4 2019, with a 5-year trough of $412000.0 in Q4 2020.
  • In the last 4 years, Cogent Biosciences' Accumulated Depreciation & Amortization had a median value of $2.8 million in 2017 and averaged $2.7 million.
  • Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first soared by 6036.7% in 2018, then crashed by 9110.34% in 2020.
  • Quarter analysis of 4 years shows Cogent Biosciences' Accumulated Depreciation & Amortization stood at $2.2 million in 2017, then surged by 60.37% to $3.5 million in 2018, then surged by 32.47% to $4.6 million in 2019, then plummeted by 91.1% to $412000.0 in 2020.
  • Its last three reported values are $412000.0 in Q4 2020, $4.6 million for Q4 2019, and $3.5 million during Q4 2018.